FDA Approves Pfizer’s COVID Booster for Children

 Newest authorization keeps younger demographic vaccinated

The Food and Drug Administration (FDA) announced on Tuesday that they have approved Pfizer and BioNTech’s COVID-19 vaccine booster shot for children aged 5 to 11. The CDC still needs to give their approval to fully recommend these boosters for the younger demographic, but this approval allows President Biden’s administration to continue to address the spread of COVID-19.

“While it has largely been the case that COVID-19 tends to be less severe in children than adults, the Omicron wave has seen more kids getting sick with the disease and being hospitalized,” FDA Commissioner Robert Califf stated. The COVID-19 vaccines have shown to decrease in effectiveness over time, and booster shots are expected to prevent the spread of the virus.

As the Lord Leads, Pray with Us…

  • For FDA Commissioner Califf to seek God’s direction as he oversees his agency’s authorizations.
  • For CDC Director Walensky as she evaluates data regarding public health threats.
  • For scientists and researchers as they test therapies and medical interventions.

Sources: The Hill, Reuters


Back to top